Coagulation factor ix recombinant Intravenous and Ranibizumab ophthalmic
Determining the interaction of Coagulation factor ix recombinant Intravenous and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: coagulation factor ix
Brand name: Alphanine SD, Alprolix, BeneFIX, Idelvion, Ixinity, Mononine, Rebinyn, Rixubis, BeneFIX 250 Int'l Units, BeneFIX
Synonyms: Coagulation factor IX, Factor IX (Human)
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Coagulation factor ix recombinant Intravenous-Ranitidine
- Coagulation factor ix recombinant Intravenous-Ranitidine Capsule
- Coagulation factor ix recombinant Intravenous-Ranitidine Hydrochloride
- Coagulation factor ix recombinant Intravenous-Ranitidine Injection
- Coagulation factor ix recombinant Intravenous-Ranitidine Suspension
- Coagulation factor ix recombinant Intravenous-Ranitidine Syrup
- Ranibizumab ophthalmic-Coagulation factor ix recombinant, glycopegylated Intravenous
- Ranibizumab ophthalmic-Coagulation factor VIIa injection
- Ranibizumab ophthalmic-Coagulation factor viia Intravenous
- Ranibizumab ophthalmic-Coagulation factor X
- Ranibizumab ophthalmic-Coal Tar and Salicylic Acid
- Ranibizumab ophthalmic-Coal Tar Cream, Gel, and Ointment